
Novartis has announced that the President of its oncology business, Bruno Strigini, is to retire next year, citing personal reasons …

Novartis has hired Merck’s president of Europe and Canada Bruno Strigini to be its president of oncology. The role was …
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland
New CCO Ogburn joins Cori Clinical
Claris reports visual acuity gains with experimental LSCD treatment
Amphista doses first patient in AML trial of protein degrader

